Literature DB >> 25074422

Comprehensive ultra-performance liquid chromatographic separation and mass spectrometric analysis of eicosanoid metabolites in human samples.

Yan Wang1, Aaron M Armando2, Oswald Quehenberger3, Chao Yan4, Edward A Dennis5.   

Abstract

Over the past decade, the number of known eicosanoids has expanded immensely and we have now developed an ultra-performance liquid chromatography-electrospray ionization triple quadrupole mass spectrometric (UPLC-QTRAP/MS/MS) method to monitor and quantify numerous eicosanoids. The UPLC-QTRAP/MS/MS approach utilizes scheduled multiple reaction monitoring (MRM) to optimize sensitivity, number of metabolites that can be analyzed and the time requirement of the analysis. A total of 184 eicosanoids including 26 deuterated internal standards can be separated and monitored in a single 5min UPLC run. To demonstrate a practical application, human plasma samples were analyzed following solid-phase extraction (SPE) and the recovery rate and matrix effects were determined for the 26 deuterated internal standards added to the plasma. The method was validated and shown to be sensitive with the limit of quantitation at pg levels for most compounds, accurate with recovery rates of 70-120%, and precise with a CV<30 for all compounds. Also, the method showed a linear response over a range spanning several orders of magnitude. In a QC human plasma sample, we identified and rigorously quantified over 120 eicosanoids.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Eicosanoids; Lipidomics; Plasma; Tandem mass spectrometry; Ultra-performance liquid chromatography

Mesh:

Substances:

Year:  2014        PMID: 25074422      PMCID: PMC4592635          DOI: 10.1016/j.chroma.2014.07.006

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  29 in total

Review 1.  The human plasma lipidome.

Authors:  Oswald Quehenberger; Edward A Dennis
Journal:  N Engl J Med       Date:  2011-11-10       Impact factor: 91.245

Review 2.  LC-MS-based metabolomics in the clinical laboratory.

Authors:  Susen Becker; Linda Kortz; Christin Helmschrodt; Joachim Thiery; Uta Ceglarek
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-10-22       Impact factor: 3.205

3.  Automated targeting analysis of eicosanoid inflammation biomarkers in human serum and in the exometabolome of stem cells by SPE-LC-MS/MS.

Authors:  Carlos Ferreiro-Vera; José María Mata-Granados; Feliciano Priego-Capote; José Manuel Quesada-Gómez; María Dolores Luque de Castro
Journal:  Anal Bioanal Chem       Date:  2010-11-16       Impact factor: 4.142

4.  High-throughput lipidomic analysis of fatty acid derived eicosanoids and N-acylethanolamines.

Authors:  Darren S Dumlao; Matthew W Buczynski; Paul C Norris; Richard Harkewicz; Edward A Dennis
Journal:  Biochim Biophys Acta       Date:  2011-06-13

Review 5.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

6.  A highly efficient, high-throughput lipidomics platform for the quantitative detection of eicosanoids in human whole blood.

Authors:  Jiao Song; Xuejun Liu; Jiejun Wu; Michael J Meehan; Jonathan M Blevitt; Pieter C Dorrestein; Marcos E Milla
Journal:  Anal Biochem       Date:  2012-10-26       Impact factor: 3.365

7.  Validation and application of an LC-MS/MS method for quantitation of three fatty acid ethanolamides as biomarkers for fatty acid hydrolase inhibition in human plasma.

Authors:  Wenying Jian; Richard Edom; Naidong Weng; Peter Zannikos; Zhiming Zhang; Hao Wang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-04-22       Impact factor: 3.205

8.  Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products.

Authors:  Masayuki Wada; Cynthia J DeLong; Yu H Hong; Caroline J Rieke; Inseok Song; Ranjinder S Sidhu; Chong Yuan; Mark Warnock; Alvin H Schmaier; Chieko Yokoyama; Emer M Smyth; Stephen J Wilson; Garret A FitzGerald; R Michael Garavito; De Xin Sui; John W Regan; William L Smith
Journal:  J Biol Chem       Date:  2007-05-22       Impact factor: 5.157

9.  Application of Doehlert uniform shell designs for selecting optimal amounts of internal standards in the analysis of prostaglandins and leukotrienes by liquid chromatography-tandem mass spectrometry.

Authors:  Pedro Araujo; Steve Janagap; Elisabeth Holen
Journal:  J Chromatogr A       Date:  2012-08-23       Impact factor: 4.759

10.  Quantitative profiling of oxylipins through comprehensive LC-MS/MS analysis: application in cardiac surgery.

Authors:  Katrin Strassburg; Annemarie M L Huijbrechts; Kirsten A Kortekaas; Jan H Lindeman; Theresa L Pedersen; Adrie Dane; Ruud Berger; Arjan Brenkman; Thomas Hankemeier; John van Duynhoven; Eric Kalkhoven; John W Newman; Rob J Vreeken
Journal:  Anal Bioanal Chem       Date:  2012-07-20       Impact factor: 4.142

View more
  47 in total

Review 1.  Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs.

Authors:  Melissa Gabbs; Shan Leng; Jessay G Devassy; Md Monirujjaman; Harold M Aukema
Journal:  Adv Nutr       Date:  2015-09-15       Impact factor: 8.701

2.  Evaluating lipid mediator structural complexity using ion mobility spectrometry combined with mass spectrometry.

Authors:  Jennifer E Kyle; Noor Aly; Xueyun Zheng; Kristin E Burnum-Johnson; Richard D Smith; Erin S Baker
Journal:  Bioanalysis       Date:  2018-03-01       Impact factor: 2.681

Review 3.  Eicosanoid storm in infection and inflammation.

Authors:  Edward A Dennis; Paul C Norris
Journal:  Nat Rev Immunol       Date:  2015-07-03       Impact factor: 53.106

4.  Tear eicosanoids in healthy people and ocular surface disease.

Authors:  Yohannes Abere Ambaw; Cecilia Chao; Shanshan Ji; Manfred Raida; Federico Torta; Markus R Wenk; Louis Tong
Journal:  Sci Rep       Date:  2018-07-26       Impact factor: 4.379

Review 5.  Liberating Chiral Lipid Mediators, Inflammatory Enzymes, and LIPID MAPS from Biological Grease.

Authors:  Edward A Dennis
Journal:  J Biol Chem       Date:  2016-08-23       Impact factor: 5.157

6.  Quantitative determination of esterified eicosanoids and related oxygenated metabolites after base hydrolysis.

Authors:  Oswald Quehenberger; Signe Dahlberg-Wright; Jiang Jiang; Aaron M Armando; Edward A Dennis
Journal:  J Lipid Res       Date:  2018-10-15       Impact factor: 5.922

7.  Biomarkers of NAFLD progression: a lipidomics approach to an epidemic.

Authors:  D Lee Gorden; David S Myers; Pavlina T Ivanova; Eoin Fahy; Mano R Maurya; Shakti Gupta; Jun Min; Nathanael J Spann; Jeffrey G McDonald; Samuel L Kelly; Jingjing Duan; M Cameron Sullards; Thomas J Leiker; Robert M Barkley; Oswald Quehenberger; Aaron M Armando; Stephen B Milne; Thomas P Mathews; Michelle D Armstrong; Chijun Li; Willie V Melvin; Ronald H Clements; M Kay Washington; Alisha M Mendonsa; Joseph L Witztum; Ziqiang Guan; Christopher K Glass; Robert C Murphy; Edward A Dennis; Alfred H Merrill; David W Russell; Shankar Subramaniam; H Alex Brown
Journal:  J Lipid Res       Date:  2015-01-17       Impact factor: 5.922

Review 8.  Targeted lipidomic strategies for oxygenated metabolites of polyunsaturated fatty acids.

Authors:  Giuseppe Astarita; Alexandra C Kendall; Edward A Dennis; Anna Nicolaou
Journal:  Biochim Biophys Acta       Date:  2014-12-05

9.  Profiling of Serum Oxylipins During the Earliest Stages of Rheumatoid Arthritis.

Authors:  Javier Rodríguez-Carrio; Roxana Coras; Mercedes Alperi-López; Patricia López; Catalina Ulloa; Francisco Javier Ballina-García; Aaron M Armando; Oswald Quehenberger; Mónica Guma; Ana Suárez
Journal:  Arthritis Rheumatol       Date:  2021-01-29       Impact factor: 10.995

10.  PLA2G5 regulates transglutaminase activity of human IL-4-activated M2 macrophages through PGE2 generation.

Authors:  Munehiro Yamaguchi; Jennifer Zacharia; Tanya M Laidlaw; Barbara Balestrieri
Journal:  J Leukoc Biol       Date:  2016-03-02       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.